Ovarian Cancer

SOG: Intraperitoneal chemo ups ovarian cancer survival

(HealthDay)—Intraperitoneal (IP) chemotherapy is associated with improved survival in advanced ovarian cancer compared with standard intravenous (IV) therapy, according to a study presented at the Society ...

Mar 12, 2013
popularity not rated yet | comments 0

Origin of aggressive ovarian cancer discovered

Cornell University researchers have discovered a likely origin of epithelial ovarian cancer (ovarian carcinoma), the fifth leading cause of cancer death among women in the United States.

Mar 06, 2013
popularity 5 / 5 (1) | comments 0 | with audio podcast

Researchers discover breakthrough in ovarian cancer

Researchers at The University of Arizona Cancer Center at St. Joseph's Hospital and Medical Center in Phoenix have discovered that many women with low-grade serous carcinoma of the ovary or peritoneum have seen their tumors ...

Feb 14, 2013
popularity 5 / 5 (3) | comments 0 | with audio podcast

Ovarian cancer risk reduced by prolonged lactation

Curtin University researchers have found that women who breastfeed their babies have significantly reduced rates of ovarian cancer in a study that extends what was known about the beneficial effects of breastfeeding on mothers.

Feb 01, 2013
popularity 5 / 5 (1) | comments 0

Two-step immunotherapy attacks advanced ovarian cancer

Most ovarian cancer patients are diagnosed with late stage disease that is unresponsive to existing therapies. In a new study, researchers from the Perelman School of Medicine at the University of Pennsylvania School of Medicine ...

Jan 31, 2013
popularity 5 / 5 (1) | comments 0

Latest Spotlight News

Turning off depression in the brain

Scientists have traced vulnerability to depression-like behaviors in mice to out-of-balance electrical activity inside neurons of the brain's reward circuit and experimentally reversed it – but there's ...

Building 'smart' cell-based therapies

A Northwestern University synthetic biology team has created a new technology for modifying human cells to create programmable therapeutics that could travel the body and selectively target cancer and other ...